Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy
- Conditions
- Malignant Neoplasm
- Interventions
- Other: Educational InterventionOther: Survey Administration
- Registration Number
- NCT04278534
- Lead Sponsor
- OHSU Knight Cancer Institute
- Brief Summary
This trial studies the use of virtual reality as an educational tool for cancer patients undergoing radiation therapy. The purpose of the study is to learn about virtual reality education (VERT) and if it may be able to help people who are planning to receive radiation therapy. Patient education using virtual reality may result in better understanding and/or decreased anxiety in patients receiving radiation therapy.
- Detailed Description
PRIMARY OBJECTIVE:
I. To assess if proximal knowledge regarding radiation therapy (RT) treatment is improved as result of radiation therapist-led education sessions utilizing VERT.
SECONDARY OBJECTIVE:
I. To assess if proximal anxiety related to first RT is reduced as result of radiation therapist-led education sessions utilizing VERT.
EXPLORATORY OBJECTIVES:
I. To determine whether self-reported knowledge changes throughout course of RT treatment.
II. To evaluate if self-reported knowledge related to RT treatment differs by patient and tumor characteristics (gender, age, diagnosis, type of cancer, etc.).
III. To determine whether the level of patient knowledge and/or anxiety changes throughout radiation RT treatment.
IV. To evaluate if the level of anxiety related to RT treatment differs by patient and tumor characteristics (gender, age, diagnosis, type of cancer, etc.).
V. To characterize the levels informational support provided by interprofessional RT treatment team needs and knowledge gaps of cancer patients undergoing RT treatment.
VI. To determine the sources of information related to RT treatment being accessed by study participants.
VII. To assess self-reported satisfaction in knowledge gained regarding RT treatment.
VIII. To compare the baseline proximal knowledge and anxiety of Oregon Health and Science University (OHSU) patients with Compass Oncology patients.
OUTLINE: Patients are either randomized to Arm I or 1 of 2 groups of Arm II, or assigned to the observational cohort.
ARM I: Patients complete a radiation therapist-led education module using virtual reality over 30 minutes at the first treatment appointment, prior to radiation therapy treatment.
ARM II: Patients are randomized to 1 of 2 groups.
ARM II CONTROL GROUP I: Patients receive the usual verbal and written education materials at the first treatment appointment, prior to radiation therapy treatment.
ARM II CONTROL GROUP II: Patients complete a radiation therapist-led face-to-face education module at the first treatment appointment, prior to radiation therapy treatment.
OBSERVATIONAL COHORT: Observational patients receive the usual verbal and written education materials at the first treatment appointment, prior to radiation therapy treatment.
After completion of study, patients are optionally followed up periodically.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 27
- Ability to understand and the willingness to sign a written informed consent document
- All races and ethnic groups will be included
- Participants with any cancer diagnosis that is intended to receive RT for curative intent for their cancer
- Participants must have a minimum of 10 planned RT treatments
- Any prior RT
- Known history of anxiety or depression
- Individuals with known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Any condition that, in the opinion of the investigator, would interfere with evaluation of study treatment or interpretation of participant safety or study results
- Inability to understand either English or Spanish
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm II Control Group I (usual education materials) Survey Administration Patients receive the usual verbal and written education materials at the first treatment appointment, prior to radiation therapy treatment. Observational Cohort (usual education materials) Educational Intervention Observational patients receive the usual verbal and written education materials at the first treatment appointment, prior to radiation therapy treatment. Arm II Control Group I (usual education materials) Educational Intervention Patients receive the usual verbal and written education materials at the first treatment appointment, prior to radiation therapy treatment. Arm II Control Group II (face-to-face education module) Survey Administration Patients complete a radiation therapist-led face-to-face education module at the first treatment appointment, prior to radiation therapy treatment. Arm I (VERT) Educational Intervention Patients complete a radiation therapist-led education module using virtual reality over 30 minutes at the first treatment appointment, prior to radiation therapy treatment. Arm I (VERT) Survey Administration Patients complete a radiation therapist-led education module using virtual reality over 30 minutes at the first treatment appointment, prior to radiation therapy treatment. Arm II Control Group II (face-to-face education module) Educational Intervention Patients complete a radiation therapist-led face-to-face education module at the first treatment appointment, prior to radiation therapy treatment. Observational Cohort (usual education materials) Survey Administration Observational patients receive the usual verbal and written education materials at the first treatment appointment, prior to radiation therapy treatment.
- Primary Outcome Measures
Name Time Method Knowledge of radiation therapy (RT) Prior to start of planned RT, on the first treatment day up to completion of the virtual reality education (VERT) intervention of planned RT (up to 9 weeks) Measured by part 1 of the Radiation Therapy Patient Education Survey by start of RT. The sum of scores from Survey 1.1 for Arm 1 will be compared with that of Arm 2 (using total scores from Survey 1.0 for Arm 2 control group \[CG\]1 and total scores from Survey 1.1 for Arm 2 CG2) using two-sided two-sample t test. Linear regression models will be fitted for adjusted comparison after controlled for disease sites and other important patient and tumor characteristics.
- Secondary Outcome Measures
Name Time Method Anxiety in radiation therapy Prior to start of planned RT, on the first treatment day up to completion of the VERT intervention of planned RT (up to 9 weeks) Measured by part 2 of the Radiation Therapy Patient Education Survey by start of RT. The sum of scores from Survey 1.1 for Arm 1 will be compared with that of Arm 2 (using total scores from Survey 1.0 for Arm 2 CG1 and total scores from Survey 1.1 for Arm 2 CG2) using two-sided two-sample t test. Linear regression models will be fitted for adjusted comparison after controlled for disease sites and other important patient and tumor characteristics.
Trial Locations
- Locations (2)
Compass Oncology Rose Quarter
🇺🇸Portland, Oregon, United States
OHSU Knight Cancer Institute
🇺🇸Portland, Oregon, United States